William Gardner’s Post

Discover the power of viral vectors in gene therapy! Our new infographic offers a comprehensive overview of their types, key selection criteria, benefits, and production processes. #GeneTherapy #ViralVectors https://lnkd.in/eyaj5F47

A Laboratory Information Management System (#LIMS) is crucial for managing the complexities of gene therapy research. Learn how LIMS can streamline workflows, ensure data integrity, and accelerate discoveries in this transformative field. Read more in the latest Sapio Sciences blog post. #LIMS #GeneTherapy #LabInformatics

The growing importance of oligonucleotides in research, diagnostics and gene therapy, including tRNA, siRNA, and other modified oligonucleotides up to 120 bases, increased the need for tools to verify their sequence as well as identify and quantify related impurities. Explore our website to discover how our mass spectrometry solutions, along with the OligoQuest™ software, can efficiently deliver trustworthy results for you! #Oligo#massspectrometry

Everything you need to know about GENE THERAPY for hemophilia A and B. First illustrated review describing basic principles, current evidence &clinical implementation by Cihan Ay et al published in @haemophilia journal It has been a wonderful experience curating the illustrations for the team. Art4Science (https://lnkd.in/e5eiWVtF) https://lnkd.in/eU2jv33N #genetherapy #haematology #hemophilia

My thoughts on Cell & Gene Therapy Deveopment from a CMC and regulatory strategy perspective captured in a vlog by Darwin Shurig.

Overcome challenges like tedious revalidation and costly optimization during cell and gene therapy scale-up. With scalable technologies and flexible formats, we help you avoid problems with yield and process consistency, so you can meet increasing patient demand efficiently: https://sar.to/73hd8 #SimplifyingProgress #InThisTogether #AdvancedTherapies #CellandGeneTherapy

🔬 We are back with another “Ask a Virologist”! Cell & gene therapy manufacturing is challenging, and a lot of effort goes into establishing a production platform. At Virica we understand the need to enhance CGT productivity without disrupting your current platform. This week, Keara Sutherland, talks about how our Viral Sensitizer (VSEᵀᴹ) can be: ✔ Seamlessly integrated into your production process without disruption. ✔ Rapidly metabolized leaving no residues. 👇 Check out the video to know more! In case you missed the other videos in the series! Our unique mode of action: https://lnkd.in/dusFXNwK What makes VSEs broadly applicable to various virus and cell line combinations and applications: https://lnkd.in/dHxMEGtt Follow along as we highlight the unique aspects of VSEs! 👉 If you find this series valuable subscribe to our newsletter for all things CGT! https://lnkd.in/d-rf3XVX #biomanufacturing #innovation #QandAs #askavirologist

Cell and Gene Therapy in the Asia-Pacific Region https://lnkd.in/ek89D7BS 2 Key Challenges for Access For cell and gene therapy (CGT) manufacturers seeking entry in the Asia Pacific (APAC) region, the still-emerging local value chains, overreliance on global resources, and a thriving local landscape present a highly competitive and capital-intensive environment. This update explores the access challenges that CGTs face in the APAC context https://lnkd.in/ek89D7BS #MarketAccess #HEOR #WeAreAvalereHealth

Learn how a publicly traded gene therapy company struggled to identify an optimal vector design to carry forward after 15 rounds of empirical optimization over three years. By applying AI/ML models, Form Bio was able to identify four optimal vector designs within days that resulted in 91% full capsids. The company was able to advance a lead and backup candidate to next steps. Explore the methods and results: https://hubs.li/Q02LwKgs0 #VectorDiscovery #AAV #GeneTherapy #InSilico

Cell and gene therapy in the Asia-Pacific region https://lnkd.in/efNFUyFj learnings from local case studies. In this update, we share two case studies that explore how local innovators in the cell and gene therapy space in Asia-Pacific are addressing some of the major challenges for access in the region: that of overcoming complex manufacturing and delivery and improving affordability. https://lnkd.in/efNFUyFj #MarketAccess #HEOR #WeAreAvalereHealth